Lv5
1140 积分 2023-08-26 加入
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis
1个月前
已完结
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
7个月前
已完结
The next generation of immunotherapies for lung cancers
7个月前
已完结
皖公网安备34019202002308
